Related references
Note: Only part of the references are listed.Inhibitors Targeting Mitosis: Tales of How Great Drugs against a Promising Target Were Brought Down by a Flawed Rationale
Edina Komlodi-Pasztor et al.
CLINICAL CANCER RESEARCH (2012)
Overexpression of Aurora-A promotes laryngeal cancer progression by enhancing invasive ability and chromosomal instability
Hao Zhang et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2012)
Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death
V. Ratushny et al.
ONCOGENE (2012)
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
Mark G. Manfredi et al.
CLINICAL CANCER RESEARCH (2011)
Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma
Heini Lassus et al.
GYNECOLOGIC ONCOLOGY (2011)
Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas
Koji Matsuo et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
Preclinical Evaluation of AMG 900, a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines
Marc Payton et al.
CANCER RESEARCH (2010)
CAS proteins in normal and pathological cell growth control
Nadezhda Tikhmyanova et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
MLN8054, an Inhibitor of Aurora A Kinase, Induces Senescence in Human Tumor Cells Both In vitro and In vivo
Jessica J. Huck et al.
MOLECULAR CANCER RESEARCH (2010)
MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel
Toshiyasu Shimomura et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents
Deborah R. Wysong et al.
CELL CYCLE (2009)
Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model
Anis Feki et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
AURORA KINASE A INHIBITION AND PACLITAXEL AS TARGETED COMBINATION THERAPY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA
Abhijit Mazumdar et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Applications of bioluminescence imaging to antiviral research and therapy: Multiple luciferase enzymes and quantitation
Kathryn E. Luker et al.
ANTIVIRAL RESEARCH (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells
Xiang-Bo Wan et al.
CARCINOGENESIS (2008)
Aurora kinases as anticancer drug targets
Oliver Gautschi et al.
CLINICAL CANCER RESEARCH (2008)
Targeting Aurora kinase with MK-0457 inhibits ovarian cancer growth
Yvonne G. Lin et al.
CLINICAL CANCER RESEARCH (2008)
Aurora-a, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells
Zhong Guan et al.
CANCER RESEARCH (2007)
A new central scaffold for metastasis: Parsing HEF1le/Cas-L/NEDD9
Geraldine M. O'Neill et al.
CANCER RESEARCH (2007)
LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji et al.
NATURE (2007)
Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients
Charles N. Landen et al.
CLINICAL CANCER RESEARCH (2007)
Predictive value of Aurora-A/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy
Silke Lassmann et al.
CLINICAL CANCER RESEARCH (2007)
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
Mark G. Manfredi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The suppression of Aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma
Eiji Tanaka et al.
CLINICAL CANCER RESEARCH (2007)
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells
Thuy-Vy Do et al.
MOLECULAR CANCER RESEARCH (2007)
Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells (Publication with Expression of Concern. See vol. 144, 2019)
Hua Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Mechanisms of transcoelomic metastasis in ovarian cancer
David S. P. Tan et al.
LANCET ONCOLOGY (2006)
Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma
Rudolf Reiter et al.
CLINICAL CANCER RESEARCH (2006)
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene
Minjung Kim et al.
CELL (2006)
HEF1-Aurora A interactions - Points of dialog between the cell cycle and cell attachment signaling networks
Elena N. Pugacheva et al.
CELL CYCLE (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome
EN Pugacheva et al.
NATURE CELL BIOLOGY (2005)
Amplification and overexpression of Aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells
CM Chung et al.
MOLECULAR CARCINOGENESIS (2005)
RNA interference targeting aurora kinase A suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells
T Hata et al.
CANCER RESEARCH (2005)
Identification of V23RalA-Ser194 as a critical mediator for aurora-A-induced cellular motility and transformation by small pool expression screening
JC Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Centrosome abnormalities in ovarian cancer
LC Hsu et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis
M Tatsuka et al.
ONCOGENE (2005)
Progress in the development of selective inhibitors of Aurora kinases
A Mortlock et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Aurora-kinase inhibitors as anticancer agents
N Keen et al.
NATURE REVIEWS CANCER (2004)
Overexpression of aurora-A contributes to malignant development of human esophageal squamous cell carcinoma
T Tong et al.
CLINICAL CANCER RESEARCH (2004)
Aurora-a kinase maintains the fidelity of early and late mitotic events in HeLa cells
T Marumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol
S Anand et al.
CANCER CELL (2003)
Share Paper
